Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT04526704
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
32 Enrollment(s)
16 Study location(s)
INTERVENTIONAL (PHASE4)
Tenosynovial Giant Cell Tumor
RECRUITING
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
413 Enrollment(s)
100 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Cancer
RECRUITING
NCT04356209
Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life
105 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
TERMINATED
NCT04100135
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
7 Enrollment(s)
15 Study location(s)
INTERVENTIONAL (NA)
Migraine


Patent Foramen Ovale


PFO - Patent Foramen Ovale
RECRUITING
NCT04047641
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
80 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia


Blasts 20 Percent or More of Bone Marrow Nucleated Cells


High Risk Myelodysplastic Syndrome


Recurrent Acute Biphenotypic Leukemia


Recurrent Acute Myeloid Leukemia


Recurrent High Risk Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia


Refractory High Risk Myelodysplastic Syndrome
ACTIVE_NOT_RECRUITING
NCT04042701
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
115 Enrollment(s)
30 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


Non-small Cell Lung Carcinoma
COMPLETED
NCT03996772
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
319 Enrollment(s)
64 Study location(s)
INTERVENTIONAL (PHASE3)
Atrial Fibrillation


Intracerebral Hemorrhage
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
948 Enrollment(s)
152 Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages


Atrial Fibrillation